MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhee, M.-H.
Right arrow Articles by Vogel, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhee, M.-H.
Right arrow Articles by Vogel, Z.

Vol. 57, Issue 4, 746-752, April 2000

Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1 Cannabinoid Receptor1

Man-Hee Rhee, Igal Nevo, Tomer Avidor-Reiss, Rivka Levy, and Zvi Vogel

Department of Neurobiology, The Weizmann Institute of Science, Rehovot, Israel

Many types of cells exhibit increased adenylyl cyclase (AC) activity after chronic agonist treatment of Gi/o-coupled receptors. This phenomenon, defined as AC superactivation or sensitization, has mostly been studied for the opioid receptors and is implicated in opiate addiction. Here we show that this phenomenon is also observed on chronic activation of the CB1 cannabinoid receptor. Moreover, using COS-7 cells cotransfected with CB1 receptor and individual AC isozymes, we could show selective superactivation of AC types I, III, V, VI, and VIII. The level of superactivation was dependent on the concentration of agonist and time of agonist exposure and was not dependent on the AC stimulator used. No superactivation of AC types II, IV, or VII was observed in COS-7 cells cotransfected with CB1. The superactivation of AC type V was abolished by pretreatment with pertussis toxin and by cotransfection with the carboxy terminus of beta -adrenergic receptor kinase, which serves as a scavenger of Gbeta gamma dimers, implying a role for the Gi/o proteins and especially Gbeta gamma dimers in the cannabinoid-induced superactivation of AC.

1 This work was supported by the Israel Science Foundation. Z.V. is the incumbent of the Ruth and Leonard Simon Chair for Cancer Research.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
M. A. Beazely, J. K. Alan, and V. J. Watts
Protein Kinase C and Epidermal Growth Factor Stimulation of Raf1 Potentiates Adenylyl Cyclase Type 6 Activation in Intact Cells
Mol. Pharmacol., January 1, 2005; 67(1): 250 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. A. Vortherms, C. H. Nguyen, C. H. Berlot, and V. J. Watts
Using Molecular Tools to Dissect the Role of G{alpha}s in Sensitization of AC1
Mol. Pharmacol., December 1, 2004; 66(6): 1617 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. E. Selley, M. P. Cassidy, B. R. Martin, and L. J. Sim-Selley
Long-Term Administration of {Delta}9-Tetrahydrocannabinol Desensitizes CB1-, Adenosine A1-, and GABAB-Mediated Inhibition of Adenylyl Cyclase in Mouse Cerebellum
Mol. Pharmacol., November 1, 2004; 66(5): 1275 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Jarrahian, V. J. Watts, and E. L. Barker
D2 Dopamine Receptors Modulate G{alpha}-Subunit Coupling of the CB1 Cannabinoid Receptor
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 880 - 886.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. J. Watts
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 1 - 7.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv., June 1, 2002; 2(3): 168 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. G. Cumbay and V. J. Watts
Heterologous Sensitization of Recombinant Adenylate Cyclases by Activation of D2 Dopamine Receptors
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1201 - 1209.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni
Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens
J. Neurosci., January 1, 2001; 21(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics